MM

Merit Medical Systems, Inc.

MMSIHealthcareNASDAQ

Medical Instruments & Supplies

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.52B
+11.8% YoY
Net Income
$128.5M
+6.8% YoY
EBITDA
$332.0M
+12.2% YoY
Free Cash Flow
$173.9M

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 24 RSI OverboughtRSI 70.1, above 70, stock may be overbought
Aug 22 RSI OverboughtRSI 70.1, above 70, stock may be overbought
About Merit Medical Systems, Inc.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United. Valued at $5.35B, MMSI is a mid-cap name in its sector. It operates through two segments, Cardiovascular and Endoscopy.

Where MMSI stands vs its 150-day and 200-day moving averages

As of the August 24, 2026 close, MMSI finished 24.14% above its 150-day moving average ($73.13) and 18.70% above its 200-day moving average ($76.48). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is MMSI overbought or oversold?

At the August 24, 2026 close, MMSI's RSI(14) was 70.1, in overbought territory (above 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$5.35B
P/E (TTM)36.87
Fwd P/E19.43
EPS$2.43
Beta0.49
52W Change-2.3%
ROE9.2%
Analysis

The company holds $448.7M in cash, though total debt stands at $820.1M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $173.9M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 9.2% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.15B (2022) to $1.52B (2025), reflecting a 32% increase over the period.

With a beta below 0.7, Merit Medical Systems, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. No single metric tells the full story. Reviewing MMSI's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms